Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 198

Results For "WHO"

2357 News Found

Lilly's bamlanivimab with etesevimab authorized for emergency use in Covid-19 patients under 12
Drug Approval | December 06, 2021

Lilly's bamlanivimab with etesevimab authorized for emergency use in Covid-19 patients under 12

Expanded EUA includes both treatment of patients with Covid-19 and post-exposure prophylaxis (PEP) in high-risk pediatric and infant patients


Ophthalmologists converge in Chennai to discuss latest innovations
Events | December 05, 2021

Ophthalmologists converge in Chennai to discuss latest innovations

IIRSI 2021 aims to bring together ophthalmologists across India and abroad to discuss the advancement in technology and their experience in IOL implantation and Refractive Surgery


Aster Volunteers offer free diabetes screening in India and UAE
Events | December 03, 2021

Aster Volunteers offer free diabetes screening in India and UAE

In 2019, diabetes was the ninth leading cause of death with an estimated 1.5 million deaths directly caused by diabetes, as per WHO


North America accounts for 50 % of generic pharma market
News | December 03, 2021

North America accounts for 50 % of generic pharma market

Going forward, the fastest-growing regions in the generic pharmaceuticals market will be South America and the Middle East, where growth will be at CAGRs of 10.1% and 9.4% respectively


Neuberg Diagnostics expands to North India
Diagnostic Center | December 03, 2021

Neuberg Diagnostics expands to North India

Collectively, these 10 laboratories are capable of processing about 10,000 samples in a day and deliver results within the given turnaround time


Booster dose  for those above 40
News | December 03, 2021

Booster dose for those above 40

The recommendation was made by the Indian SARS-CoV-2 Genomics Sequencing Consortium (INSACOG), a network of national testing labs set up by the government to monitor genomic variations of Covid-19


Serum seeks DCGI approval for booster dose in India
News | December 02, 2021

Serum seeks DCGI approval for booster dose in India

The UK’s Medicine and Healthcare products Regulatory Agency has already approved the booster dose of AstraZenenca’s Covid-19 vaccine, which is administered in India


Molnupiravir, a step closer to approval in the fight against Covid-19
News | December 02, 2021

Molnupiravir, a step closer to approval in the fight against Covid-19

The U.S. FDA advisory committee voted 13-10 in favour of the oral antiviral medicine


Lupin partners with TTP for soft-mist inhalation tech platform
Biotech | December 02, 2021

Lupin partners with TTP for soft-mist inhalation tech platform

Soft-mist inhalation (SMI) technology allows for delivery of inhalation drugs from a small, portable hand-held inhaler device without the use of propellants


GSK's antibody drug sotrovimab works against Omicron mutations
Biotech | December 02, 2021

GSK's antibody drug sotrovimab works against Omicron mutations

Preclinical data demonstrate sotrovimab, authorised in multiple countries around the world, retains activity against all tested variants of concern, including key mutations of Omicron